Skip to main content

UBS Group AG

Position in GLSI — Greenwich LifeSciences, Inc.

CIK 1610520 ZURICH, V8

Position in GLSI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$549,174
+$41,969 QoQ
Shares Held
23,409
+10.9% QoQ
Ownership
0.159%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 57 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GLSI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. GLSI ranks #288 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GLSI

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $549,174 23,409
2026-03-31 $507,205 21,116
2025-12-31 $127,739 6,080
2025-09-30 $40,854 4,106
2025-06-30 $16,734 1,845
2025-03-31 $30,489 3,196
2024-12-31 $73,634 6,557
2024-09-30 $40,336 2,807
2024-06-30 $31,188 1,807
2024-03-31 $8,015 402
2023-12-31 $19,356 1,840
2023-09-30 $8 1
2023-06-30 $2,198 228
2023-03-31 $13 1
2022-12-31 $11,004 724
2022-09-30 $16,461 1,809
2022-06-30 $7,368 870
2022-03-31 $16,186 825
2021-12-31 $67,247 2,764
2021-09-30 $168,391 4,310
2021-06-30 $34,154 760
2021-03-31 $10,533 309
2020-12-31 $32,093 880
2020-09-30 $1,274 277